Restoring sight after whole human eye transplant remains a long-term goal, and the optic nerve is the limiting factor, ...
At AAO 2026, Adam, MD, shares Yamane technique pearls, from docking the trailing haptic to preventing tilt and haptic ...
Alvotech and Advanz Pharma have submitted a European regulatory application for AVT29, a proposed biosimilar to high-dose ...
Many patients diagnosed with dry eye are actually experiencing ocular pain that may stem from the ocular surface, the nerves, ...
Innovation in therapeutics has a lot on the horizon, he said, but all of those drugs and innovations can only be delivered by ...
At AAO 2026, Michael T. Yen, MD, explained how at-home subcutaneous elegrobart could ease treatment burden in thyroid eye ...
Wilmer Eye Institute, Johns Hopkins University, ...
Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...
Talley Rostov is a partner at Northwest Eye Surgeons in Seattle, Washington, and serves as a board member and medical liaison for SightLife. She is a consultant for Glaukos.
Koreishi, MD, explains why inflammation control and planning are key to cataract surgery for patients with uveitis.
The US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to ...
Ehsan Rahimy, MD, says most PRIMA serious adverse events occurred early, while vision gains held through 36 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results